137 related articles for article (PubMed ID: 6610200)
61. Lack of hepatic benefit by oxygen inhalation during vasopressin infusion in patients with cirrhosis.
Iwao T; Toyonaga A; Sumino M; Oho K; Sakaki M; Ikegami M; Nishizono M; Tanikawa K
J Gastroenterol Hepatol; 1992; 7(3):249-52. PubMed ID: 1611013
[TBL] [Abstract][Full Text] [Related]
62. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.
Bosch J; Groszmann RJ; García-Pagán JC; Terés J; García-Tsao G; Navasa M; Mas A; Rodés J
Hepatology; 1989 Dec; 10(6):962-8. PubMed ID: 2511136
[TBL] [Abstract][Full Text] [Related]
63. The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Padrini R; Finucci GF; Angeli P; Ruol A
Br J Clin Pharmacol; 1988 Sep; 26(3):273-7. PubMed ID: 3179167
[TBL] [Abstract][Full Text] [Related]
64. Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices.
Bendtsen F; Henriksen JH; Sørensen TI
Scand J Gastroenterol; 1991 Sep; 26(9):933-9. PubMed ID: 1947785
[TBL] [Abstract][Full Text] [Related]
65. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding.
Hwang SJ; Lin HC; Chang CF; Lee FY; Lu CW; Hsia HC; Wang SS; Lee SD; Tsai YT; Lo KJ
J Hepatol; 1992 Nov; 16(3):320-5. PubMed ID: 1487608
[TBL] [Abstract][Full Text] [Related]
66. Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow.
Krejci V; Hiltebrand LB; Jakob SM; Takala J; Sigurdsson GH
Crit Care; 2007; 11(6):R129. PubMed ID: 18078508
[TBL] [Abstract][Full Text] [Related]
67. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.
Lebrec D; De Fleury P; Rueff B; Nahum H; Benhamou JP
Gastroenterology; 1980 Dec; 79(6):1139-44. PubMed ID: 6969201
[TBL] [Abstract][Full Text] [Related]
68. Bleeding colonic varices controlled by propranolol.
McAlpine LG; Birnie GG; Hilditch TE; Dagg JH
Scott Med J; 1988 Dec; 33(6):370-1. PubMed ID: 3266683
[TBL] [Abstract][Full Text] [Related]
69. Efficacy of selective splanchnic arteriography and vasopressin perfusion in diagnosis and treatment of gastrointestinal hemorrhage.
Johnson WC; Widrich WC
Am J Surg; 1976 Apr; 131(4):481-9. PubMed ID: 1083677
[TBL] [Abstract][Full Text] [Related]
70. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure.
Ready JB; Robertson AD; Goff JS; Rector WG
Gastroenterology; 1991 May; 100(5 Pt 1):1403-10. PubMed ID: 2013385
[TBL] [Abstract][Full Text] [Related]
71. Vascular responses of small intestine and liver to regional infusion of vasopressin.
Fasth S; Haglund U; Hultén L; Nordgren S
Acta Chir Scand; 1981; 147(7):583-8. PubMed ID: 7345850
[TBL] [Abstract][Full Text] [Related]
72. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs.
Blei AT; Groszmann RJ; Gusberg R; Conn HO
Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592
[TBL] [Abstract][Full Text] [Related]
73. Long-term hemodynamic effects of portocaval shunt and Sugiura procedure in patients with cirrhosis.
Vons C; Hadengue A; Smadja C; Franco D; Lebrec D
HPB Surg; 1996; 9(4):209-13. PubMed ID: 8809580
[TBL] [Abstract][Full Text] [Related]
74. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
75. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
[TBL] [Abstract][Full Text] [Related]
76. Treatment of bleeding oesophageal varices by infusion of vasopressin into the superior mesenteric artery.
Murray-Lyon IM; Pugh RN; Nunnerley HB; Laws JW; Dawson JL; Williams R
Gut; 1973 Jan; 14(1):59-63. PubMed ID: 4540294
[TBL] [Abstract][Full Text] [Related]
77. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
[TBL] [Abstract][Full Text] [Related]
78. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
79. High-dose vasopressin for acute variceal hemorrhage. Clinical advantages without adverse effects.
Sirinek KR; Levine BA
Arch Surg; 1988 Jul; 123(7):876-80. PubMed ID: 3260096
[TBL] [Abstract][Full Text] [Related]
80. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
